Related content

Patient subgroup analyses of the treatment effect of subcutaneous interferon β-1a on development of multiple sclerosis in the randomized controlled REFLEX study

By Freedman Mark   Stefano Nicola   Barkhof Frederik   Polman Chris   Comi Giancarlo   Uitdehaag Bernard   Casset-Semanaz Florence   Hennessy Brian   Lehr Lorenz   Stubinski Bettina   Jack Dominic   Kappos Ludwig  

Journal of Neurology, Vol. 261, Iss. 3, 2014-03 ,pp. : 490-499

Springer Publishing Company

Access to resources Recommend Favorite

Aktuelle Entwicklungen in der klinischen Interferon-β-1b-Forschung

By Knappertz V.  

Der Nervenarzt, Vol. 80, Iss. 1, 2009-07 ,pp. : 64-64

Springer Publishing Company

Access to resources Recommend Favorite

Interferon β bei schubförmiger MS: Verträglichkeit, Therapieadhärenz und Lebensqualität in den ersten 3 Behandlungsmonaten

By Schwarz S.   Bertsch T.   Knorr C.   Schmidt C.   Leweling H.  

Der Nervenarzt, Vol. 80, Iss. 1, 2009-07 ,pp. : 18-19

Springer Publishing Company

Access to resources Recommend Favorite

Overexpression of Interferon α/β Receptor β Chain in Fetal Down Syndrome Brain

By  

Neuroembryology and Aging, Vol. 2, Iss. 4, 2004-11 ,pp. : 147-155

Karger

Access to resources Recommend Favorite

Apyrase and 5′-nucleotidase Activities in Synaptosomes from the Cerebral Cortex of Rats Experimentally Demyelinated with Ethidium Bromide and Treated with Interferon-β

By Spanevello R. M.   Mazzanti C.   Kaizer R.   Zanin R.   Cargnelutti D.   Hannel L.   Côrrea M.   Mazzanti A.   Festugatto R.   Graça D.   Schetinger M.   Morsch V.  

Neurochemical Research, Vol. 31, Iss. 4, 2006-04 ,pp. : 455-462

Springer Publishing Company

Access to resources Recommend Favorite